Top Markets
#1 Black Phoenix Black Phoenix +365.30%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.04%
#5 Akedo Akedo +36.85%
#6 BasedHype BasedHype +32.76%
#7 Acurast Acurast +28.33%
#8 Cryptopia Cryptopia +21.42%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +20.60%
#10 GoPlus Security GoPlus Security +19.08%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Marizyme, Inc. Marizyme, Inc.

Marizyme, Inc.

MRZM
Rank in Stocks #41141
Marizyme, Inc. is a life sciences company primarily engaged in bringing... Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and bypass surgeries, engineered to maintain the function and structure of the endothelium, along with other critical characteristics. The company is also progressing with various therapeutic products utilizing its Krillase protease-based platform. These are being developed to address conditions such as severe wounds and burns, acute ischemic stroke, deep vein thrombosis, and for the removal of dental plaque and biofilms. Additionally, Marizyme focuses on creating solutions to mitigate the damaging effects of ischemia-reperfusion injury in different grafting and organ transplantation procedures, among other medical applications. A further key initiative is the development of MATLOC, a digital, point-of-care, lab-on-chip device platform designed for the screening and diagnosis of chronic kidney disease. Established in 2007, Marizyme, Inc., previously known as GBS Enterprises Incorporated, is headquartered in Jupiter, Florida.
Share Price
$0.0003
Last synced: 2026-08-11
Market Cap
$39.54K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Marizyme, Inc. (MRZM)

Category

Healthcare
Stock price history for Marizyme, Inc. (MRZM)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $1.01 on 2010-11-01
Stock price history of Marizyme, Inc. from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -98.90%
2024 -78.19%
2023 -86.16%
2022 -43.23%
2021 -36.30%
2020 294.78%
2019 -52.41%
2018 6,568.42%
2017 -53.33%
2016 -45.18%
2015 -50.00%
2014 13.62%
2013 -40.42%
2012 -88.61%
2011 58.26%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $745.48 9.02%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.24 16.81%
BE